Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
PerkinElmer management to meet with Cowen » 08:34
02/13/20
02/13
08:34
02/13/20
08:34
PKI

PerkinElmer

$96.43 /

+0.57 (+0.59%)

Meeting to be held in…

Meeting to be held in Boston on February 13 hosted by Cowen.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
Hot Stocks
Fly Intel: After Hours Movers » 18:57
01/27/20
01/27
18:57
01/27/20
18:57
GGG

Graco

$51.41 /

-0.605 (-1.16%)

, BRO

Brown & Brown

$41.70 /

-0.145 (-0.35%)

, IPAR

Inter Parfums

$70.67 /

-1.33 (-1.85%)

, XLRN

Acceleron

$52.83 /

+0.81 (+1.56%)

, SURF

Surface Oncology

$2.93 /

-0.13 (-4.25%)

, MNOV

MediciNova

$6.10 /

-0.26 (-4.09%)

, LAUR

Laureate Education

$17.70 /

+0.04 (+0.23%)

, FFIV

F5 Networks

$132.71 /

-3.14 (-2.31%)

, RMBS

Rambus

$14.57 /

-0.38 (-2.54%)

, JNPR

Juniper

$24.46 /

-0.12 (-0.49%)

, PKI

PerkinElmer

$98.74 /

-1.075 (-1.08%)

, JJSF

J & J Snack Foods

$184.54 /

-2.31 (-1.24%)

, ALEC

Alector

$25.72 /

+1.17 (+4.77%)

, DNLI

Denali Therapeutics

$27.97 /

+3.29 (+13.33%)

UP AFTER EARNINGS: Graco…

UP AFTER EARNINGS: Graco (GGG) up 4.6%... Brown&Brown (BRO) up 2.0%... Inter Parfums (IPAR) up 1.0%. ALSO HIGHER: Acceleron Pharma (XLRN) up 66.1% after announcing its sotatercept trial met endpoints... Surface Oncology (SURF) up 13.8% after getting FDA clearance for SRF617, SRF388 INDs... MediciNova (MNOV) up 11.3% after getting notice of intention to grant patent for MN-001 in Europe... Laureate Education (LAUR) up 4.5% after announcing plans to explore strategic alternatives. DOWN AFTER EARNINGS: F5 Networks (FFIV) down 4.5%... Rambus (RMBS) down 3.2%... Juniper (JNPR) down 2.9%... PerkinElmer (PKI) down 2.7%... J&J Snack Foods (JJSF) down 2.0%. ALSO LOWER: Alector (ALEC) down 2.8% after equity offering... Denali Therapeutics (DNLI) down 2.7% after equity offering. Movers as of 18:45ET.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29
    Jan
  • 30
    Jan
Hot Stocks
PerkinElmer falls 2.7% after Q4 earnings, below-consensus FY20 guidance » 16:43
01/27/20
01/27
16:43
01/27/20
16:43
PKI

PerkinElmer

$98.74 /

-1.075 (-1.08%)

Shares of PerkinElmer are…

Shares of PerkinElmer are down 2.7% or $2.67 at $96 per share after the company reported Q4 results and guided Q1 and FY20 below consensus.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
PerkinElmer reports Q4 operating margin 23.9% vs. 21.7% last year  16:18
01/27/20
01/27
16:18
01/27/20
16:18
PKI

PerkinElmer

$98.79 /

-1.025 (-1.03%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
PerkinElmer sees Q1 EPS 70c, consensus 84c » 16:17
01/27/20
01/27
16:17
01/27/20
16:17
PKI

PerkinElmer

$98.79 /

-1.025 (-1.03%)

Sees Q1 revenue $700M,…

Sees Q1 revenue $700M, consensus $699.93M

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
PerkinElmer guides initial FY20 EPS $4.50-$4.60, consensus $4.63 » 16:16
01/27/20
01/27
16:16
01/27/20
16:16
PKI

PerkinElmer

$98.79 /

-1.025 (-1.03%)

Sees FY20 revenue…

Sees FY20 revenue $3.05B-$3.09B, consensus $3.08B.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
PerkinElmer reports Q4 adjusted EPS $1.35, consensus $1.33 » 16:15
01/27/20
01/27
16:15
01/27/20
16:15
PKI

PerkinElmer

$98.79 /

-1.025 (-1.03%)

Reports Q4 revenue…

Reports Q4 revenue $805.5M, consensus $800.98M.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Thermo Fisher, PerkinElmer slip after Illumina issues guidance at JPMorgan event  11:37
01/13/20
01/13
11:37
01/13/20
11:37
TMO

Thermo Fisher

$328.74 /

-0.14 (-0.04%)

, PKI

PerkinElmer

$100.67 /

+0.38 (+0.38%)

, ILMN

Illumina

$336.59 /

+1.16 (+0.35%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
PerkinElmer initiated with an Equal Weight at Wells Fargo » 16:21
01/07/20
01/07
16:21
01/07/20
16:21
PKI

PerkinElmer

$98.80 /

+0.835 (+0.85%)

Wells Fargo analyst Dan…

Wells Fargo analyst Dan Leonard initiated coverage of PerkinElmer with an Equal Weight rating and $105 price target.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
PerkinElmer initiated with a Neutral at Citi » 16:35
01/06/20
01/06
16:35
01/06/20
16:35
PKI

PerkinElmer

$97.97 /

+0.975 (+1.01%)

Citi analyst Patrick…

Citi analyst Patrick Donnelly initiated coverage of PerkinElmer with a Neutral rating and $100 price target.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.